Research Labs

Mechanisms of genetic and epigenetic cooperativity which drive myeloid transformation; Elucidating and modeling evolution from hematopoietic stem/progenitor cells to clonal hematopoiesis and then to myeloid malignancies; Identification and credentialing novel therapeutic dependencies in myeloid malignancies

Immunologist Ming Li studies mechanisms of immune regulation, and their relevance to diseases including cancer.

Dr. Yueming Li studies disease mechanism of Cancer and Alzheimer’s, with the goal of developing novel therapeutics for clinical use.

Physician-scientist Megan Lim studies the molecular pathogenesis of lymphoma.

The Long laboratory investigates the molecular mechanisms of ion channels and enzymatic membrane proteins and seeks to use these discoveries to benefit humanity.

Chemical Biologist Minkui Luo develops cutting-edge tools, technologies and concepts to annotate functions of protein-posttranslational modifications and designs inhibitors for cancer therapies.

Molecular biologist John Maciejowski studies the causes of complex chromosome rearrangements and the patterns of hypermutation that shape cancer genomes.

The Maura Lab is an energetic, highly collaborative, in-person team that combines clinical, computational, and molecular biology—leveraging bulk and single-cell genomics and close MSKCC clinical partnerships—to uncover genomic drivers of lymphoproliferative disorders and translate them into earlier detection and more personalized treatments.

Molecular and cell biologist Christine Mayr studies how 3′UTRs regulate protein functions and how mRNAs contribute to cytoplasmic organization.